Investigation of age and smoking in NSCLC patients with uncommon EGFR mutations.

Yosuke Maezawa, Manato Taguchi, Takeshi Kawakami, Toshihide Inui, Shinichiro Okauchi, Takeshi Numata, Toshihiro Shiozawa, Kunihiko Miyazaki, Ryota Nakamura, Kesato Iguchi, Takeo Endo, Tohru Sakamoto, Hiroaki Satoh, Nobuyuki Hizawa
{"title":"Investigation of age and smoking in NSCLC patients with uncommon EGFR mutations.","authors":"Yosuke Maezawa, Manato Taguchi, Takeshi Kawakami, Toshihide Inui, Shinichiro Okauchi, Takeshi Numata, Toshihiro Shiozawa, Kunihiko Miyazaki, Ryota Nakamura, Kesato Iguchi, Takeo Endo, Tohru Sakamoto, Hiroaki Satoh, Nobuyuki Hizawa","doi":"10.5578/tt.202402913","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>In addition to the two common epidermal growth factor receptor (EGFR) mutations, there are many uncommon mutations. Due to the high number of uncommon types, as well as the rarity of patients, there is lack of information regarding patient demographics, especially age distribution and smoking status. Against this background, we conducted an analysis to clarify the background of patients with uncommon EGFR mutations, especially considering their age distribution and smoking status.</p><p><strong>Materials and methods: </strong>We retrospectively reviewed the medical records of non-small cell lung cancer (NSCLC) patients diagnosed in a multicenter clinical practice from 2002 to 2023. Patients included all cases of non-advanced and advanced NSCLC with uncommon EGFR mutations.</p><p><strong>Result: </strong>Information on 158 patients with uncommon EGFR mutation was collected. Median age was 72 years, with the age distribution showing that most patients were in their 70s. There was a significant difference between the proportion of patients aged up to 59 years and the proportion aged 75 years or older. In 88 patients with a smoking habit history, a significant correlation was found between smoking index and age. Among non-smokers, there was a peak between ages 70 and 74, which was older than the peak among smokers.</p><p><strong>Conclusions: </strong>Even in elderly patients and NSCLC patients with a history of smoking, although it is unclear whether EGFR mutation is common or uncommon, EGFR gene testing should be performed considering the possibility of these patients being EGFR-positive.</p>","PeriodicalId":519894,"journal":{"name":"Tuberkuloz ve toraks","volume":"72 2","pages":"107-113"},"PeriodicalIF":0.0000,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11390093/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Tuberkuloz ve toraks","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5578/tt.202402913","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: In addition to the two common epidermal growth factor receptor (EGFR) mutations, there are many uncommon mutations. Due to the high number of uncommon types, as well as the rarity of patients, there is lack of information regarding patient demographics, especially age distribution and smoking status. Against this background, we conducted an analysis to clarify the background of patients with uncommon EGFR mutations, especially considering their age distribution and smoking status.

Materials and methods: We retrospectively reviewed the medical records of non-small cell lung cancer (NSCLC) patients diagnosed in a multicenter clinical practice from 2002 to 2023. Patients included all cases of non-advanced and advanced NSCLC with uncommon EGFR mutations.

Result: Information on 158 patients with uncommon EGFR mutation was collected. Median age was 72 years, with the age distribution showing that most patients were in their 70s. There was a significant difference between the proportion of patients aged up to 59 years and the proportion aged 75 years or older. In 88 patients with a smoking habit history, a significant correlation was found between smoking index and age. Among non-smokers, there was a peak between ages 70 and 74, which was older than the peak among smokers.

Conclusions: Even in elderly patients and NSCLC patients with a history of smoking, although it is unclear whether EGFR mutation is common or uncommon, EGFR gene testing should be performed considering the possibility of these patients being EGFR-positive.

非常见表皮生长因子受体突变的 NSCLC 患者的年龄和吸烟情况调查。
引言除了两种常见的表皮生长因子受体(EGFR)突变外,还有许多不常见的突变。由于不常见突变类型较多,且患者罕见,因此缺乏有关患者人口统计学方面的信息,尤其是年龄分布和吸烟状况。在此背景下,我们进行了一项分析,以明确不常见表皮生长因子受体突变患者的背景,尤其是考虑到他们的年龄分布和吸烟状况:我们回顾性地查阅了2002年至2023年期间在多中心临床实践中确诊的非小细胞肺癌(NSCLC)患者的病历。患者包括所有具有不常见表皮生长因子受体(EGFR)突变的非晚期和晚期NSCLC病例:结果:共收集到158例不常见表皮生长因子受体突变患者的信息。中位年龄为 72 岁,年龄分布显示大多数患者为 70 多岁。59岁以下患者的比例与75岁或以上患者的比例存在明显差异。在 88 名有吸烟史的患者中,吸烟指数与年龄之间存在显著相关性。在非吸烟者中,70 岁至 74 岁是一个高峰,比吸烟者的高峰年龄要大:结论:即使是老年患者和有吸烟史的NSCLC患者,虽然还不清楚表皮生长因子受体基因突变是常见还是不常见,但考虑到这些患者表皮生长因子受体基因阳性的可能性,应进行表皮生长因子受体基因检测。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信